Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery
Author(s): James Gammie Added: 2 years ago
In this short interview, Dr James Gammie (University of Maryland Medical Center, MD, US) discusses the findings from surgical trial assessing the benefit of concomitant tricuspid repair during mitral valve surgery. The trial, presented at AHA 2021, demonstrated that at 2 years, TA had no impact on MACCE, survival, or QOL. Discussion Points 1. Reasoning for this Study 2. Study Design and… View more

Vascular Disease and Surgery

Intervention
Author(s): Manuel J Antunes Added: 3 years ago
After the advent of the heart–lung machine, which permitted open-heart surgery, in 1953, valve surgery was one of the most important advances in cardiac surgery. Initially, only conservative procedures were possible, but the first orthotopic human implantation of an artificial valve, by Starr in 1960, permitted the replacement of most cardiac valves not amenable to repair. Since then, more than a… View more

Intervention
ESC 23: The SurHyb Trial
Author(s): Alan Bulava Added: 7 months ago
ESC 2023 — Dr Alan Bulava (Ceske Budejovice Hospital and University of South Bohemia, CZ) joins us in this succinct interview to discuss the findings from the SurHyb trial. The SurHyb study was a prospective, open-label-multicentre randomized trial. The study aimed to evaluate CryoMaze surgery alone, as compared to CryoMaze followed by radiofrequency catheter ablation 3-months post-surgery. … View more

Electrophysiology & Arrhythmia
A Pieter Kappetein
Research Area(s) / Expertise: Job title: Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program
Dr. Pieter Kappetein, MD, PhD, is a Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program at the Thoraxcenter at the Erasmus Medical Centre in Rotterdam, The Netherlands. He is board certified in Cardiothoracic Surgery. His specialty is cardiothoracic surgery. He is Secretary General of the European Association for Cardio-thoracic Surgery, President of CTSnet and member… View more
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 6 months ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more
Joseph C Cleveland Jr
Job title: Associate Professor, Cardiothoracic Surgery
Personal History Dr Joseph Cornelius Cleveland, Jr. was born in Philadelphia, Pennsylvania.He is a Thoracic and Cardiac Surgeon and an Associate Professor of Cardiothoracic Surgery at the University of Colorado Anschutz Medical Center, Aurora, CO.Dr Cleveland has a wife and two sons. His other interests are golf and travel.1 Academic History Dr Cleveland obtained his BSc in… View more
Tricuspid Regurgitation Therapy
Author(s): Qiuyu Martin Zhu , Natalia Berry Added: 6 months ago

Heart Failure
Contemporary Management of Secondary Mitral Regurgitation
Author(s): Kashish Goel , Colin M Barker , JoAnn Lindenfeld Added: 3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural… View more

Vascular Disease and Surgery

Heart Failure
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 5 months ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention